Abbott Wants Sales Of Rival Glucose Monitor Barred For Now
A subsidiary of Abbott Laboratories urged a London court Wednesday to bar medical devices rival Sinocare Inc. from mass marketing a glucose monitoring system that it argues is highly similar to...To view the full article, register now.
Already a subscriber? Click here to view full article